Watch Verizon, EQT, and ARM
In Tuesday morning trade, watch shares of Verizon Communications (VZ) follow through with Monday’s rally. VZ stock gained 4.04% to close at $42.49 after posting quarterly results. This ended a downtrend that started in late February.Verizon posted a 5% Y/Y revenue increase, to $34.5 billion. It led the industry with $20.9 billion in wireless equipment revenue. The firm expects to post adjusted EBITDA and EPS growth. In 2025, it will spend $17.5-$18.5 billion in capital expenditure. VZ stock is attractive for its dividend.EQT dropped by 9.55% on no business news. It might have fallen in sympathy with EOG Resources (EOG), Devon Energy (DVN), and Occidental Petroleum (OXY) trading lower.ARM Holdings (ARM) continued an uptrend that began in April. It continues to benefit from generative AI computing demand. For example, ARM-based chips grew by 14-fold since 2021, to 70,000, as of July 9. Chip makers are racing to catch up to Nvidia (NVDA). Alphabet’s (GOOG) Google unit has Tensor chips that cost less than Nvidia’s products. AMD should report growing market share as demand increases for its MI400 series AI accelerator, expected to launch in 2026.Analysts are bullish on ARM stock. UBS and Wells Fargo recently increased their price targets to $175 and $185, respectively.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


